Cardinal Health (CAH) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CAH Stock Forecast

Cardinal Health stock forecast is as follows: an average price target of $100.64 (represents a -14.95% downside from CAH’s last price of $118.33) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.

CAH Price Target

The average price target for Cardinal Health (CAH) is $100.64 based on 1-year price targets from 16 Wall Street analysts in the past 3 months, with a price target range of $140.00 to $53.00. This represents a potential -14.95% downside from CAH's last price of $118.33.

CAH Analyst Ratings

Buy

According to 16 Wall Street analysts, Cardinal Health's rating consensus is 'Buy'. The analyst rating breakdown for CAH stock is 0 'Strong Buy' (0.00%), 9 'Buy' (56.25%), 5 'Hold' (31.25%), 2 'Sell' (12.50%), and 0 'Strong Sell' (0.00%).

Cardinal Health Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Sep 23, 2024	Eric Coldwell	Robert W. Baird	$140.00	$112.30	24.67%	18.31%
Sep 11, 2024	David Toung	Argus Research	$125.00	$112.36	11.25%	5.64%
Aug 16, 2024	George Hill	Deutsche Bank	$119.00	$107.91	10.28%	0.57%
Aug 15, 2024	Elizabeth Anderson	Evercore ISI	$115.00	$107.71	6.77%	-2.81%
Aug 15, 2024	Erin Wright	Morgan Stanley	$119.00	$106.36	11.88%	0.57%
Aug 15, 2024	Ann Hynes	Mizuho Securities	$110.00	$107.39	2.43%	-7.04%
Aug 15, 2024	Eric Coldwell	Robert W. Baird	$137.00	$107.33	27.64%	15.78%
Aug 15, 2024	Stephen Baxter	Wells Fargo	$101.00	$106.36	-5.04%	-14.65%
Jun 11, 2024	Garrett Nelson	CFRA	$111.00	$99.01	12.11%	-6.19%
May 29, 2024	Eric Coldwell	Robert W. Baird	$129.00	$94.75	36.15%	9.02%

Row per page

Go to

The latest Cardinal Health stock forecast, released on Sep 23, 2024 by Eric Coldwell from Robert W. Baird, set a price target of $140.00, which represents a 24.67% increase from the stock price at the time of the forecast ($112.30), and a 18.31% increase from CAH last price ($118.33).

Cardinal Health Price Target by Period

	1M	3M	12M
# Anlaysts	-	2	13
Avg Price Target	-	$132.50	$121.77
Last Closing Price	$118.33	$118.33	$118.33
Upside/Downside	-100.00%	11.97%	2.91%

In the current month, the average price target of Cardinal Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Cardinal Health's last price of $118.33. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Sep 23, 2024	Cowen & Co.	Hold	Hold	Hold
Aug 16, 2024	Deutsche Bank	Hold	Hold	Hold
Aug 15, 2024	Cowen & Co.	Hold	Hold	Hold
Aug 15, 2024	Evercore ISI	Outperform	Outperform	Hold
Aug 15, 2024	Cowen & Co.	Buy	Buy	Hold
Aug 15, 2024	Morgan Stanley	Overweight	Overweight	Hold
Aug 14, 2024	Wells Fargo	Underweight	Underweight	Hold
Aug 14, 2024	Argus Research	Buy	Buy	Hold
Aug 14, 2024	UBS	Buy	Buy	Hold
May 02, 2024	Morgan Stanley	Overweight	Overweight	Hold

Row per page

Go to

Cardinal Health's last stock rating was published by Cowen & Co. on Sep 23, 2024. The company gave CAH a "Hold" rating, the same as its previous rate.

Cardinal Health Financial Forecast

Cardinal Health Revenue Forecast

	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$57.45B	$54.76B	$53.45B	$50.49B	$51.47B	$49.60B	$47.10B	$44.84B	$45.46B	$44.84B	$42.59B	$39.06B	$41.54B	$39.27B	$36.69B	$37.34B
Avg Forecast	$72.66B	$63.49B	$65.61B	$62.75B	$64.10B	$57.97B	$59.54B	$57.20B	$59.27B	$53.61B	$54.04B	$50.90B	$58.64B	$56.05B	$57.02B	$54.85B	$52.72B	$49.71B	$50.72B	$48.19B	$44.89B	$43.12B	$45.59B	$41.84B	$40.39B	$40.06B	$41.41B	$38.16B	$36.85B	$37.00B
High Forecast	$74.29B	$64.91B	$67.08B	$64.16B	$65.54B	$59.26B	$60.87B	$58.48B	$60.60B	$55.10B	$54.79B	$52.04B	$58.64B	$56.05B	$57.50B	$55.49B	$53.90B	$50.82B	$51.86B	$48.19B	$44.89B	$43.12B	$45.59B	$41.84B	$40.39B	$40.06B	$41.41B	$38.16B	$36.85B	$37.00B
Low Forecast	$70.12B	$61.27B	$63.32B	$60.56B	$61.86B	$55.94B	$57.45B	$55.20B	$57.19B	$52.52B	$53.37B	$49.11B	$58.64B	$56.05B	$56.80B	$53.90B	$50.87B	$47.97B	$48.95B	$48.19B	$44.89B	$43.12B	$45.59B	$41.84B	$40.39B	$40.06B	$41.41B	$38.16B	$36.85B	$37.00B
# Analysts	4	7	6	4	4	6	4	3	7	9	9	4	4	4	5	8	5	4	4	3	4	3	5	4	5	4	5	9	9	9
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.01%	1.00%	1.01%	1.02%	1.01%	1.03%	1.05%	1.04%	1.00%	1.07%	1.05%	0.98%	1.00%	1.03%	1.00%	1.01%

Cardinal Health's average Quarter revenue forecast for Mar 24 based on 4 analysts is $56.05B, with a low forecast of $56.05B, and a high forecast of $56.05B. CAH's average Quarter revenue forecast represents a -2.42% decrease compared to the company's last Quarter revenue of $57.45B (Dec 23).

Cardinal Health EBITDA Forecast

	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
# Analysts	4	7	6	4	4	6	4	3	7	9	9	4	4	4	5	8	5	4	4	3	4	3	5	4	5	4	5	9	9	9
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$691.00M	$-14.00M	$666.00M	$707.00M	$578.00M	$515.00M	$512.00M	$644.00M	$563.00M	$644.00M	$436.00M	$654.00M	$724.00M	$792.00M	$585.00M	$660.00M
Avg Forecast	$107.45M	$93.88M	$97.02M	$92.80M	$94.79M	$85.72M	$88.04M	$84.59M	$87.64M	$79.28M	$79.91M	$75.26M	$86.71M	$103.13M	$84.31M	$81.11M	$77.96M	$93.76M	$-821.58M	$686.83M	$639.88M	$85.24M	$649.90M	$596.43M	$575.72M	$691.81M	$590.29M	$543.97M	$525.28M	$659.89M
High Forecast	$109.86M	$95.99M	$99.20M	$94.88M	$96.92M	$87.64M	$90.02M	$86.48M	$89.61M	$81.47M	$81.03M	$76.95M	$86.71M	$123.76M	$85.03M	$82.06M	$79.71M	$112.51M	$-657.27M	$686.83M	$639.88M	$102.28M	$649.90M	$596.43M	$575.72M	$830.18M	$590.29M	$543.97M	$525.28M	$791.87M
Low Forecast	$103.69M	$90.60M	$93.63M	$89.55M	$91.47M	$82.72M	$84.96M	$81.63M	$84.58M	$77.67M	$78.93M	$72.63M	$86.71M	$82.51M	$83.99M	$79.71M	$75.23M	$75.01M	$-985.90M	$686.83M	$639.88M	$68.19M	$649.90M	$596.43M	$575.72M	$553.45M	$590.29M	$543.97M	$525.28M	$527.91M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.20%	-0.17%	8.54%	7.54%	-0.70%	0.75%	0.80%	7.56%	0.87%	1.08%	0.76%	0.95%	1.23%	1.46%	1.11%	1.00%

4 analysts predict CAH's average Quarter EBITDA for Mar 24 to be $103.13M, with a high of $123.76M and a low of $82.51M. This is -85.07% lower than Cardinal Health's previous annual EBITDA (Dec 23) of $691.00M.

Cardinal Health Net Income Forecast

	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
# Analysts	4	7	6	4	4	6	4	3	7	9	9	4	4	4	5	8	5	4	4	3	4	3	5	4	5	4	5	9	9	9
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$353.00M	$5.00M	$-64.00M	$345.00M	$-130.00M	$110.00M	$138.00M	$-1.39B	$49.00M	$-1.39B	$116.00M	$119.00M	$629.00M	$120.00M	$656.00M	$350.00M
Avg Forecast	$595.35M	$661.34M	$546.24M	$538.54M	$538.88M	$585.12M	$490.21M	$495.70M	$493.02M	$538.76M	$433.03M	$396.63M	$424.81M	$-1.77B	$391.36M	$343.96M	$365.95M	$-1.61B	$52.15M	$229.61M	$289.78M	$-1.46B	$301.65M	$323.45M	$293.55M	$120.54M	$353.45M	$277.69M	$220.42M	$303.50M
High Forecast	$612.69M	$680.60M	$562.15M	$554.23M	$554.58M	$602.16M	$504.48M	$510.13M	$507.38M	$551.29M	$455.17M	$406.11M	$424.82M	$-1.42B	$411.43M	$366.07M	$376.60M	$-1.29B	$62.58M	$229.61M	$293.22M	$-1.17B	$301.65M	$332.63M	$293.55M	$144.64M	$353.45M	$277.69M	$220.42M	$364.20M
Low Forecast	$568.26M	$631.24M	$521.39M	$514.04M	$514.37M	$558.49M	$467.90M	$473.14M	$470.59M	$526.23M	$359.22M	$387.14M	$424.80M	$-2.13B	$376.30M	$329.22M	$349.30M	$-1.93B	$41.72M	$229.61M	$286.33M	$-1.76B	$301.65M	$314.28M	$293.55M	$96.43M	$353.45M	$277.69M	$220.42M	$242.80M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.90%	0.01%	-0.17%	-0.21%	-2.49%	0.48%	0.48%	0.95%	0.16%	-4.30%	0.40%	0.99%	1.78%	0.43%	2.98%	1.15%

Cardinal Health's average Quarter net income forecast for Mar 24 is $-1.77B, with a range of $-2.13B to $-1.42B. CAH's average Quarter net income forecast represents a -601.73% decrease compared to the company's last Quarter net income of $353.00M (Dec 23).

Cardinal Health SG&A Forecast

	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
# Analysts	4	7	6	4	4	6	4	3	7	9	9	4	4	4	5	8	5	4	4	3	4	3	5	4	5	4	5	9	9	9
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.28B	$1.20B	$1.27B	$1.18B	$1.19B	$1.20B	$1.16B	$1.14B	$1.15B	$1.14B	$1.13B	$1.14B	$1.15B	$1.12B	$1.14B	$1.11B
Avg Forecast	$1.87B	$1.63B	$1.69B	$1.61B	$1.65B	$1.49B	$1.53B	$1.47B	$1.52B	$1.38B	$1.39B	$1.31B	$1.51B	$1.45B	$1.47B	$1.41B	$1.36B	$1.32B	$1.22B	$1.24B	$1.15B	$1.20B	$1.17B	$1.08B	$1.04B	$1.13B	$1.06B	$981.16M	$947.45M	$1.01B
High Forecast	$1.91B	$1.67B	$1.72B	$1.65B	$1.68B	$1.52B	$1.56B	$1.50B	$1.56B	$1.42B	$1.41B	$1.34B	$1.51B	$1.74B	$1.48B	$1.43B	$1.39B	$1.58B	$1.47B	$1.24B	$1.15B	$1.44B	$1.17B	$1.08B	$1.04B	$1.36B	$1.06B	$981.16M	$947.45M	$1.21B
Low Forecast	$1.80B	$1.58B	$1.63B	$1.56B	$1.59B	$1.44B	$1.48B	$1.42B	$1.47B	$1.35B	$1.37B	$1.26B	$1.51B	$1.16B	$1.46B	$1.39B	$1.31B	$1.05B	$979.94M	$1.24B	$1.15B	$957.16M	$1.17B	$1.08B	$1.04B	$907.56M	$1.06B	$981.16M	$947.45M	$808.17M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.88%	0.85%	0.93%	0.90%	0.97%	0.97%	1.00%	0.95%	0.98%	1.06%	1.09%	1.00%	1.08%	1.14%	1.20%	1.10%

Cardinal Health's average Quarter SG&A projection for Mar 24 is $1.45B, based on 4 Wall Street analysts, with a range of $1.16B to $1.74B. The forecast indicates a 12.84% rise compared to CAH last annual SG&A of $1.28B (Dec 23).

Cardinal Health EPS Forecast

	Jun 27	Mar 27	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20
# Analysts	4	7	6	4	4	6	4	3	7	9	9	4	4	4	5	8	5	4	4	3	4	3	5	4	5	4	5	9	9	9
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.44	$0.02	$-0.25	$1.35	$-0.50	$0.41	$0.51	$-5.05	$0.18	$-5.05	$0.40	$-0.86	$2.14	$0.41	$2.25	$-16.62
Avg Forecast	$2.43	$2.70	$2.23	$2.20	$2.20	$2.39	$2.00	$2.02	$2.01	$2.20	$1.77	$1.62	$1.73	$1.95	$1.60	$1.40	$1.49	$1.49	$1.14	$0.94	$1.18	$1.52	$1.23	$1.32	$1.20	$1.55	$1.44	$1.13	$0.90	$1.43
High Forecast	$2.50	$2.78	$2.29	$2.26	$2.26	$2.46	$2.06	$2.08	$2.07	$2.25	$1.86	$1.66	$1.73	$1.95	$1.68	$1.49	$1.54	$1.52	$1.17	$0.94	$1.20	$1.57	$1.23	$1.36	$1.20	$1.55	$1.44	$1.13	$0.90	$1.43
Low Forecast	$2.32	$2.58	$2.13	$2.10	$2.10	$2.28	$1.91	$1.93	$1.92	$2.15	$1.47	$1.58	$1.73	$1.95	$1.54	$1.34	$1.43	$1.46	$1.09	$0.94	$1.17	$1.48	$1.23	$1.28	$1.20	$1.55	$1.44	$1.13	$0.90	$1.43
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.90%	0.01%	-0.17%	0.91%	-0.44%	0.44%	0.43%	-3.31%	0.15%	-3.83%	0.33%	-0.55%	1.48%	0.36%	2.50%	-11.60%

According to 4 Wall Street analysts, Cardinal Health's projected average Quarter EPS for Mar 24 is $1.95, with a low estimate of $1.95 and a high estimate of $1.95. This represents a 35.65% increase compared to CAH previous annual EPS of $1.44 (Dec 23).

Cardinal Health Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
EDAP	EDAP TMS	$2.39	$19.00	694.98%	Buy
OMI	Owens & Minor	$12.41	$30.50	145.77%	Buy
ZYXI	Zynex	$7.82	$14.38	83.89%	Buy
PDCO	Patterson Companies	$20.41	$28.83	41.25%	Buy
HSIC	Henry Schein	$74.84	$77.00	2.89%	Buy
ABC	Cencora	$179.98	$171.00	-4.99%	Buy
MCK	McKesson	$615.65	$538.67	-12.50%	Buy
CAH	Cardinal Health	$118.33	$100.64	-14.95%	Buy

CAH Forecast FAQ

Is Cardinal Health a good buy?

Yes, according to 16 Wall Street analysts, Cardinal Health (CAH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 56.25% of CAH's total ratings.

What is CAH's price target?

Cardinal Health (CAH) average price target is $100.64 with a range of $53 to $140, implying a -14.95% from its last price of $118.33. The data is based on 16 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Cardinal Health stock go up soon?

According to Wall Street analysts' prediction for CAH stock, the company can go down by -14.95% (from the last price of $118.33 to the average price target of $100.64), up by 18.31% based on the highest stock price target, and down by -55.21% based on the lowest stock price target.

Can Cardinal Health stock reach $200?

CAH's average twelve months analyst stock price target of $100.64 does not support the claim that Cardinal Health can reach $200 in the near future.

What are Cardinal Health's analysts' financial forecasts?

Cardinal Health's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $238.81B (high $244.16B, low $230.45B), average EBITDA is $353.14M (high $361.05M, low $340.78M), average net income is $2.11B (high $2.17B, low $2.01B), average SG&A $6.14B (high $6.28B, low $5.92B), and average EPS is $8.61 (high $8.86, low $8.22). CAH's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $264.52B (high $270.44B, low $255.26B), average EBITDA is $391.16M (high $399.92M, low $377.47M), average net income is $2.34B (high $2.41B, low $2.23B), average SG&A $6.8B (high $6.95B, low $6.56B), and average EPS is $9.56 (high $9.84, low $9.12).

Did the CAH's actual financial results beat the analysts' financial forecasts?

Based on Cardinal Health's last annual report (Jun 2023), the company's revenue was $205.01B, beating the average analysts forecast of $201.34B by 1.83%. Apple's EBITDA was $2.47B, beating the average prediction of $36.97M by 6570.70%. The company's net income was $261M, missing the average estimation of $-962M by -127.12%. Apple's SG&A was $4.83B, missing the average forecast of $5.14B by -5.87%. Lastly, the company's EPS was $1, missing the average prediction of $5.06 by -80.23%. In terms of the last quarterly report (Dec 2023), Cardinal Health's revenue was $57.44B, beating the average analysts' forecast of $57.02B by 0.75%. The company's EBITDA was $691M, beating the average prediction of $84.31M by 719.56%. Cardinal Health's net income was $353M, missing the average estimation of $391.36M by -9.80%. The company's SG&A was $1.28B, missing the average forecast of $1.47B by -12.47%. Lastly, the company's EPS was $1.44, missing the average prediction of $1.6 by -9.85%